You are here: Fairness.com > Resources > Ethics scrutiny needed for Chinese–...

Ethics scrutiny needed for Chinese–European projects: Panel calls for joint advisory body to monitor research.

Date: September 4, 2009

Author: Daniel Cressey

QUOTE: Biomedical research collaborations between Europe and China need greater ethical oversight to combat unregulated stem-cell therapies and prevent the exploitation of clinical-trial participants.

• Read it: Nature
• Tell a friend
• Add a Comment*

Article MetaInformation:

Key People:

Key Organizations:

• Nature Publishing Group (NPG)

Subject & Geographic Categories:

• Abstract Principles
  • Control / Access / Permission
    • Sharing / Resource Allocation
  • Information
    • Measurement

• Health & Medicine
  • Health Care Business
    • Pharmaceutical / Drug / Biotech
  • Medical Ethics

• Science & Technology
  • Biology/Biotechnology
  • Research Ethics

• Asia
  • East Asia
    • China (People's Republic / Mainland)

• Europe
  • European Union (EU)

Comments:

none

• Add a Comment*

*User comments are posted without Fairness.com LLC's prior review or approval, and Fairness.com LLC takes no responsibility for them; please see our Conditions of Service Agreement.

Please send your comments and suggestions to the Webmaster. © copyright 1999-2009, Fairness.com LLC.
"Fairness.com" and "Life isn't fair... but we're working on it" are service marks of Fairness.com LLC. All rights reserved.